查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1717888

按产品、等级、应用和最终用途分類的成长因子市场—2025-2030 年全球预测

Growth Factors Market by Product, Grade, Application, End User, End- Use Applications - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计成长因素市场在 2024 年的价值将达到 21.2 亿美元，2025 年将达到 22.9 亿美元，到 2030 年将达到 33.9 亿美元，复合年增长率为 8.14%。

主要市场统计数据
基准年2024年 21.2亿美元
预计年份：2025年 22.9亿美元
预测年份 2030 33.9亿美元
复合年增长率（%） 8.14%

生长因子是现代生物医学创新的核心，对药物发现、治疗开发和先进研究方法有着深远的影响。在这种动态的情况下，公司和研究机构都投入了大量的资源来利用这些生化讯号的潜力来推动许多疾病的治疗方法进步。生长因子研究的发展以不断扩展的科学见解、改进的生物技术平台和多学科方法的整合为标誌。

在这种环境下，市场动态不断变化以满足监管要求、加速临床检验并克服製造挑战。随着技术的进步和研究资金的增加，天然和合成生长因子的开发已成为焦点，从而有望重新定义患者照护和临床结果的创新。日益关注个人化医疗和再生疗法以及满足未满足的医疗需求构成了该领域发展的支柱。

该报告探讨了市场发展背后的驱动力，并将数据洞察与相关人员的可行建议相结合。本报告旨在让决策者清楚了解定义成长因素市场的科学和经济基本面。透过采用涵盖全球趋势和细微细分的系统方法，专业人士可以更好地应对这个快速发展的行业所固有的复杂性。

塑造成长因素格局的变革

近年来，在技术突破和研究重点策略调整的推动下，市场发生了变化。分子生物学的科学进步与尖端分析技术相结合，开创了产品开发的精确性和可重复性的新时代。对尖端生物加工技术和可扩展製造方法的投资从根本上改变了市场动态，提高了产品质量，同时缩短了上市时间。

如今，整合的全球视野支持将实验室发现快速转化为可行的治疗方案。不断变化的监管环境也发挥决定性的作用，鼓励更严格的合规通讯协定，并推动公司走向透明和强大的临床检验环境。随着多个地区的监管机构加强指导方针，各行业不仅被迫在产品特性上进行创新，而且在品质保证实践上也进行创新。

数位转型也是一个关键驱动因素，它能够实现即时数据分析和预测模型来评估市场趋势和消费者需求。该领域的领导者正在利用这些技术工具来建立能够适应不断变化的市场条件的敏捷框架。总体而言，从传统方法向创新、技术主导的方法的转变正在引导行业走向一个未来，在这个未来中，提高效率和改善患者结果不再是相互排斥的目标。

关键细分洞察市场版图分析

彻底的市场区隔方法对于分析多方面的成长因素产业至关重要。这些见解是透过从几个不同但相互关联的维度分析市场得出的。按产品分类，研究涵盖了多种产品组合，包括表皮生长因子 (EGF)、纤维母细胞生长因子 (FGF)、白细胞介素、血小板衍生生长因子 (PDGF)、转化生长因子 (TGF)、肿瘤坏死因子 (TNF) 和血管内皮生长因子 (VEGF)。此细分进一步将转化生长因子 (TGF) 亚群区分为激活素、骨形成蛋白(BMP) 和 TGF-β 蛋白，每种蛋白都反映特定的生化途径和临床相关性。

按等级和产品类型进行的市场研究表明，GMP 等级和非 GMP 等级之间存在明显区别，这对于确保临床和研究环境中的适当品质和合规性至关重要。依应用进一步细分，可确定心血管疾病和糖尿病、细胞疗法、体外製造、皮肤病学研究、血液学研究、肿瘤学研究、创伤治疗研究等领域。这些应用洞察提供了详细的视图，有助于增强目标产品和整体市场策略。

看看最终用户就会发现他们的个人需求，包括受託製造厂商(CMO)、受託製造厂商(CDMO)、製药和生物技术公司以及研究中心和学术机构。每个部分都呈现出独特的需求概况、监管挑战和技术要求。同时，依最终用途细分凸显了细胞和基因治疗、再生医学产品和组织工程的重要性。这种全面的细分框架提供了对市场的多方面理解，使其能够细緻地关注满足每个子区隔的精确需求，同时也使相关人员能够识别创新和成长的关键机会。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球消费者慢性病盛行率上升
      • 全球消费者对个人化医疗的需求正在成长
      • 优先考虑生物技术和医药创新的研发
    • 限制因素
      • 与生长因子研究、开发和製造相关的高成本
    • 机会
      • 研究机构与製药公司合作开发创新生长因子疗法
      • 在生长因子治疗应用中利用数位技术
    • 任务
      • 基于生长因子的治疗方法的严格监管要求和漫长的核准流程
  • 市场区隔分析
    • 产品：VEGF、FGF由于其应用范围广泛、临床试验疗效显着，越来越受到人们的青睐。
    • 最终用户：CMO 和 CDMO 中生长因子的扩大使用，以实现生物製造解决方案和产能灵活性
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 成长因素市场：依产品

  • 介绍
  • 表皮生长因子（EGF）
  • 纤维母细胞生长因子（FGF）
  • 白细胞介素
  • 血小板衍生生长因子（PDGF）
  • 转化生长因子（TGF）
    • 活化素
    • 骨形成蛋白（BMP）
    • TGF-β蛋白
  • 肿瘤坏死因子（TNF）
  • 血管内皮生长因子（VEGF）

第七章 成长因子市场（依等级）

  • 介绍
  • GMP级
  • 非GMP级

第 8 章成长因素市场：按应用

  • 介绍
  • 心血管疾病与糖尿病
  • 细胞治疗和体外製造
  • 皮肤病学研究
  • 血液学研究
  • 肿瘤研究
  • 创伤治疗研究

第九章 成长因子市场（依最终用户）

  • 介绍
  • CMO 和 CDMO
  • 製药和生物技术公司
  • 研究中心和学术机构

第 10 章 成长因素市场（依最终用途）

  • 介绍
  • 细胞疗法
  • 基因治疗
  • 再生医学产品
  • 组织工程

11. 美洲成长因素市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太成长因子市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲成长因子市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • Abcam PLC by Danaher Corporation
  • Akron BIoTech
  • Amgen Inc.
  • Applied Biological Materials Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biopharm GmbH
  • Cell Guidance Systems LLC
  • Cell Signaling Technology, Inc.
  • Creative Bioarray
  • F. Hoffmann-La Roche AG
  • Gemini BioProducts LLC
  • Johnson & Johnson Services, Inc.
  • Leadgene Biomedical, Inc.
  • Lonza Group AG
  • Merck & Co., Inc.
  • Meridian Bioscience Inc.
  • Miltenyi BIoTec BV & Co. KG
  • Novartis AG
  • Pfizer Inc.
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Repligen Corporation
  • Reprocell Inc.
  • Rockland Immunochemicals, Inc.
  • Sartorius AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8E22B619330C

The Growth Factors Market was valued at USD 2.12 billion in 2024 and is projected to grow to USD 2.29 billion in 2025, with a CAGR of 8.14%, reaching USD 3.39 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.12 billion
Estimated Year [2025] USD 2.29 billion
Forecast Year [2030] USD 3.39 billion
CAGR (%) 8.14%

Growth factors represent a cornerstone of modern biomedical innovation, exerting a profound impact on drug discovery, therapeutic development, and advanced research methodologies. In this dynamic landscape, companies and institutions alike are investing significant resources to harness the potential of these biochemical signals to drive advancements in treatments for a multitude of diseases. The evolution of growth factor research is marked by an ever-expanding synthesis of scientific insights, improved biotechnology platforms, and the integration of multidisciplinary approaches.

Within this environment, market dynamics are continually shifting to meet regulatory requirements, accelerate clinical validations, and overcome manufacturing challenges. With technological improvements and increased research funding, the development of both natural and synthetic variants of growth factors has become a focal point, enabling innovations that promise to redefine patient care and clinical outcomes. The increased focus on personalized medicine and regenerative therapies, alongside initiatives to address unmet medical needs, forms the backbone of this sector's evolution.

In this report, we explore the driving forces behind market progress, integrating data-driven insights with practical recommendations for stakeholders. The narrative is crafted to provide decision-makers with a clear understanding of both the scientific and economic fundamentals that define the growth factors marketplace. By adopting a methodical approach that encompasses global trends and nuanced segmentation, professionals can better navigate the complexities inherent in this rapidly evolving industry.

Transformative Shifts Reshaping the Growth Factors Landscape

Recent years have witnessed transformative changes in the market, propelled by technological breakthroughs and a strategic realignment of research priorities. Scientific advancements in molecular biology, combined with state-of-the-art analytical techniques, have ushered in a new era of precision and reproducibility in product development. Investment in cutting-edge bioprocessing technologies and scalable manufacturing methods has fundamentally recalibrated market dynamics, enhancing product quality while simultaneously reducing time-to-market.

An integrated global vision now supports the rapid translation of laboratory findings into viable therapeutic solutions. The evolution in regulatory landscapes has also played a decisive role, encouraging stricter compliance protocols and pushing companies towards an environment of transparency and robust clinical validation. As regulatory agencies across multiple regions tighten guidelines, industry players are compelled to innovate not just in product features but also in quality assurance practices.

Digital transformation is another key driver, enabling real-time data analytics and predictive modelling to assess market trends and consumer needs. Leaders in the field are leveraging these technological tools to build agile frameworks capable of adapting to evolving market conditions. Overall, the shift from traditional methodologies to innovative, technology-driven approaches is steering the industry towards a future where enhanced efficiency and improved patient outcomes are no longer mutually exclusive goals.

Key Segmentation Insights: Dissecting the Market Landscape

A thorough market segmentation approach has been essential in dissecting the multifaceted growth factors industry. Insights have been derived by analyzing the market through several distinct yet interconnected dimensions. When segmented based on product, research spans a diverse portfolio including Epidermal Growth Factors (EGFs), Fibroblast Growth Factors (FGFs), Interleukins, Platelet-Derived Growth Factors (PDGFs), Transforming Growth Factor (TGF), Tumor Necrosis Factors (TNFs), and Vascular Endothelial Growth Factors (VEGFs). This segmentation further distinguishes the Transforming Growth Factor (TGF) subgroup, categorizing it into Activin, Bone Morphogenetic Proteins (BMPs), and TGF-beta Proteins, each reflective of specific biochemical pathways and clinical relevance.

Beyond product types, market studies based on grade offer an important dichotomy between GMP Grade and Non-GMP Grade materials, which is critical for ensuring appropriate quality and compliance in clinical and research settings. Further segmentation based on application identifies sectors such as cardiovascular disease and diabetes, cell therapy along with ex vivo manufacturing, dermatology research, hematology research, oncology research, and wound healing research. These application insights provide a granular view that informs both targeted product enhancement and overall market strategy.

Segmenting by end user reveals the distinct needs of Contract Manufacturing Organizations (CMO) and Contract Development and Manufacturing Organizations (CDMO), pharmaceutical and biotechnology companies, and research centers alongside academic institutes. Each of these segments exhibits unique demand profiles, regulatory challenges, and technological requirements. In parallel, segmentation based on end-use applications underscores the importance of cell therapy, gene therapy, regenerative medicine products, and tissue engineering. This comprehensive segmentation framework allows for a multidimensional understanding of the market, ensuring that initiatives are finely tuned to meet the precise demands of each sub-segment while enabling stakeholders to identify key opportunities for innovation and growth.

Based on Product, market is studied across Epidermal Growth Factors (EGFs), Fibroblast Growth Factors (FGFs), Interleukins, Platelet-Derived Growth Factors (PDGFs), Transforming Growth Factor (TGF), Tumor Necrosis Factors (TNFs), and Vascular Endothelial Growth Factors (VEGFs). The Transforming Growth Factor (TGF) is further studied across Activin, Bone Morphogenetic Proteins (BMPs), and TGF-beta Proteins.

Based on Grade, market is studied across GMP Grade and Non-GMP Grade.

Based on Application, market is studied across Cardiovascular Disease & Diabetes, Cell therapy & Ex vivo Manufacturing, Dermatology Research, Hematology Research, Oncology Research, and Wound Healing Research.

Based on End User, market is studied across CMO & CDMO, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic Institutes.

Based on End- Use Applications, market is studied across Cell Therapy, Gene Therapy, Regenerative Medicine Products, and Tissue Engineering.

Regional Perspectives: Unveiling the Global Market Opportunities

Geographic analysis has further enriched the understanding of the growth factors market by highlighting distinct regional trends and opportunities. In the Americas, robust investments in biotechnology and an established ecosystem of pharmaceutical innovation drive significant market growth, supporting a steady influx of technological advancements and clinical studies. Companies in this region benefit from streamlined regulatory processes and extensive research networks, positioning them at the forefront of industry evolution.

In the combined region of Europe, Middle East and Africa, the market is characterized by a unique blend of mature healthcare infrastructure and rising investments in medical research. This heterogeneous landscape offers substantial scope for innovation, with emerging trends in precision medicine and regulatory harmonization acting as catalysts for market expansion. Research collaboration across borders further bypasses traditional limitations, uniting traditional expertise with modern innovation.

Asia-Pacific stands out as a region of rapid growth due to escalating investments in R&D and government incentives aimed at boosting biotechnological competitiveness. A surge in clinical trials and the strategic presence of research hubs are instrumental in pushing the boundaries of growth factor applications in both therapeutic and diagnostic domains. These regional insights collectively underscore the balanced opportunities available globally, emphasizing the importance of tailored strategies that address both localized challenges and opportunities inherent in each geographical sphere.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Strategic Company Insights: Key Industry Players and their Impact

Within this competitive arena, a range of leading companies have distinguished themselves through strategic investments, innovative product development, and robust market penetration strategies. For instance, industry pioneers such as AbbVie Inc. and Amgen Inc. are leveraging their extensive resources to consistently push the envelope of technological advancements. Their commitment to research and clinical integration has paved the way for successful product launches that meet the demands of modern therapeutics.

Other notable contributions include efforts from Abcam PLC by Danaher Corporation and Bayer AG, whose research-driven approaches and strategic partnerships have positioned them as trusted leaders in the field. Akron Biotech and Applied Biological Materials Inc. are also making significant strides by targeting niche markets and emphasizing quality and efficacy in their product offerings. Becton, Dickinson and Company along with Bio-Techne Corporation provide industry benchmarks by integrating rigorous quality standards with innovative product lines.

The role of mid-sized companies and specialized institutions, such as Cell Guidance Systems LLC, Cell Signaling Technology, Inc., and Creative Bioarray, further enriches the industry landscape by highlighting the importance of agility and specialized focus. In addition, global heavyweights including F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., and Merck & Co., Inc. are achieving significant market visibility by investing in cross-functional research and forging impactful collaborations. The overall market is also being shaped by influential entities such as Lonza Group AG, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc., whose multipronged strategies ensure continuous innovation and sustained competitive advantage. Companies like Gemini BioProducts LLC, Leadgene Biomedical, Inc., Meridian Bioscience Inc., Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Repligen Corporation, Reprocell Inc., Rockland Immunochemicals, Inc., Sartorius AG, and Sino Biological, Inc. contribute crucially by addressing both mainstream and specialized market demands, thus pushing the envelope on both technological and scientific fronts. This diverse array of industry players underscores the robust competitive landscape and provides a granular understanding of the strategic direction pursued by the leading companies in the growth factors market.

The report delves into recent significant developments in the Growth Factors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Abcam PLC by Danaher Corporation, Akron Biotech, Amgen Inc., Applied Biological Materials Inc., Bayer AG, Becton, Dickinson and Company, Bio-Techne Corporation, Biopharm GmbH, Cell Guidance Systems LLC, Cell Signaling Technology, Inc., Creative Bioarray, F. Hoffmann-La Roche AG, Gemini BioProducts LLC, Johnson & Johnson Services, Inc., Leadgene Biomedical, Inc., Lonza Group AG, Merck & Co., Inc., Meridian Bioscience Inc., Miltenyi Biotec B.V. & Co. KG, Novartis AG, Pfizer Inc., Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Repligen Corporation, Reprocell Inc., Rockland Immunochemicals, Inc., Sartorius AG, Sino Biological, Inc., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders: A Strategic Blueprint

Industry leaders are strongly advised to adapt to the evolving market conditions by aligning their business processes with novel technological and regulatory paradigms. It is essential to invest in research collaborations that foster the fusion of clinical science with innovative product development. Companies should further explore opportunities to integrate digital tools for real-time market analytics, which enable proactive identification of emerging trends and more responsive decision-making.

Diversification of product portfolios while maintaining rigorous quality control standards remains an imperative strategy. Emphasis on customizing products to meet specific clinical applications and regulatory frameworks can serve as a competitive advantage. Leaders should also consider forging strategic partnerships, particularly across regions with high growth potential, ensuring that localized insights drive product adaptability and market outreach. Finally, continuous investment in employee training and advanced analytics will empower organizations to stay agile and responsive in a rapidly transforming landscape.

Conclusion: Synthesizing Market Trends and Future Directions

In conclusion, the growth factors market is standing at a pivotal juncture marked by rapid advancements in technology, evolving regulatory requirements, and the increasing convergence of multidisciplinary research. By dissecting the market through detailed segmentation frameworks and regional insights, it is evident that stakeholders are presented with a blend of challenges and opportunities that demand a balanced, innovative approach. The strategic direction of key industry players further validates the importance of aligning research, product development, and market expansion activities.

The analysis presented confirms that a combination of research innovation, partnership exploration, and digital transformation is not only beneficial but essential for gaining competitive advantage and driving long-term growth in this burgeoning field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases among consumers globally
      • 5.1.1.2. Rising consumer demand for personalized medicine globally
      • 5.1.1.3. Increasing emphasis on research and development for innovations in biotechnology and pharmaceuticals
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with R&D and manufacturing of growth factors
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborative activities among research organizations and pharmaceutical companies for development of innovative growth factor therapies
      • 5.1.3.2. Leveraging digital technologies in growth factor therapeutic applications
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements and lengthy approval processes for growth factor-based therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for VEGFs and FGFs due to their broad application spectrum and significant efficacy in clinical trials
    • 5.2.2. End User: Expanding utilization of growth factors in CMO & CDMO for bio-manufacturing solutions and flexibility in production capabilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Growth Factors Market, by Product

  • 6.1. Introduction
  • 6.2. Epidermal Growth Factors (EGFs)
  • 6.3. Fibroblast Growth Factors (FGFs)
  • 6.4. Interleukins
  • 6.5. Platelet-Derived Growth Factors (PDGFs)
  • 6.6. Transforming Growth Factor (TGF)
    • 6.6.1. Activin
    • 6.6.2. Bone Morphogenetic Proteins (BMPs)
    • 6.6.3. TGF-beta Proteins
  • 6.7. Tumor Necrosis Factors (TNFs)
  • 6.8. Vascular Endothelial Growth Factors (VEGFs)

7. Growth Factors Market, by Grade

  • 7.1. Introduction
  • 7.2. GMP Grade
  • 7.3. Non-GMP Grade

8. Growth Factors Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Disease & Diabetes
  • 8.3. Cell therapy & Ex vivo Manufacturing
  • 8.4. Dermatology Research
  • 8.5. Hematology Research
  • 8.6. Oncology Research
  • 8.7. Wound Healing Research

9. Growth Factors Market, by End User

  • 9.1. Introduction
  • 9.2. CMO & CDMO
  • 9.3. Pharmaceutical & Biotechnology Companies
  • 9.4. Research Centers & Academic Institutes

10. Growth Factors Market, by End- Use Applications

  • 10.1. Introduction
  • 10.2. Cell Therapy
  • 10.3. Gene Therapy
  • 10.4. Regenerative Medicine Products
  • 10.5. Tissue Engineering

11. Americas Growth Factors Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Growth Factors Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Growth Factors Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. New FDA approval for EGFR exon 19 and exon 21 L858R
    • 14.3.2. Core Biogenesis unveils anti-aging growth factors
    • 14.3.3. StemCultures and Qkine's partners to advance stem cell growth factor technology
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Abcam PLC by Danaher Corporation
  • 3. Akron Biotech
  • 4. Amgen Inc.
  • 5. Applied Biological Materials Inc.
  • 6. Bayer AG
  • 7. Becton, Dickinson and Company
  • 8. Bio-Techne Corporation
  • 9. Biopharm GmbH
  • 10. Cell Guidance Systems LLC
  • 11. Cell Signaling Technology, Inc.
  • 12. Creative Bioarray
  • 13. F. Hoffmann-La Roche AG
  • 14. Gemini BioProducts LLC
  • 15. Johnson & Johnson Services, Inc.
  • 16. Leadgene Biomedical, Inc.
  • 17. Lonza Group AG
  • 18. Merck & Co., Inc.
  • 19. Meridian Bioscience Inc.
  • 20. Miltenyi Biotec B.V. & Co. KG
  • 21. Novartis AG
  • 22. Pfizer Inc.
  • 23. Prospec-Tany Technogene Ltd.
  • 24. Proteintech Group, Inc.
  • 25. Repligen Corporation
  • 26. Reprocell Inc.
  • 27. Rockland Immunochemicals, Inc.
  • 28. Sartorius AG
  • 29. Sino Biological, Inc.
  • 30. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GROWTH FACTORS MARKET MULTI-CURRENCY
  • FIGURE 2. GROWTH FACTORS MARKET MULTI-LANGUAGE
  • FIGURE 3. GROWTH FACTORS MARKET RESEARCH PROCESS
  • FIGURE 4. GROWTH FACTORS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY GRADE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GROWTH FACTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GROWTH FACTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY EPIDERMAL GROWTH FACTORS (EGFS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY PLATELET-DERIVED GROWTH FACTORS (PDGFS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY ACTIVIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS (BMPS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY TGF-BETA PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY TUMOR NECROSIS FACTORS (TNFS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GROWTH FACTORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTORS (VEGFS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GROWTH FACTORS MARKET SIZE, BY GMP GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GROWTH FACTORS MARKET SIZE, BY NON-GMP GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR DISEASE & DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GROWTH FACTORS MARKET SIZE, BY CELL THERAPY & EX VIVO MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GROWTH FACTORS MARKET SIZE, BY DERMATOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GROWTH FACTORS MARKET SIZE, BY HEMATOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GROWTH FACTORS MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GROWTH FACTORS MARKET SIZE, BY WOUND HEALING RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GROWTH FACTORS MARKET SIZE, BY CMO & CDMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GROWTH FACTORS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GROWTH FACTORS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGENERATIVE MEDICINE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GROWTH FACTORS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 59. CANADA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 91. CHINA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 97. INDIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 200. ITALY GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 224. POLAND GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 230. QATAR GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM GROWTH FACTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR (TGF), 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM GROWTH FACTORS MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM GROWTH FACTORS MARKET SIZE, BY END- USE APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 288. GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 289. GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2024